KAYEPI

Serial Number 97700199
732

Registration Progress

Application Filed
Dec 1, 2022
Under Examination
Dec 19, 2023
Approved for Publication
Oct 24, 2023
Published for Opposition
Oct 24, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Dec 19, 2025 158 days

Trademark Image

KAYEPI

Basic Information

Serial Number
97700199
Filing Date
December 1, 2022
Published for Opposition
October 24, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Jun 3, 2025
Application
Pending
Classes
005 044

Rights Holder

XENON PHARMACEUTICALS INC.

03
Address
200-3650 Gilmore Way
Burnaby, B.C. V5G4W8
CA

Ownership History

XENON PHARMACEUTICALS INC.

Original Applicant
03
Burnaby, B.C. CA

XENON PHARMACEUTICALS INC.

Owner at Publication
03
Burnaby, B.C. CA

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

Next Deadline
158 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
December 19, 2025
Extension Available
Until December 19, 2024

Application History

19 events
Date Code Type Description
Jun 3, 2025 EX3G S SOU EXTENSION 3 GRANTED
Jun 3, 2025 EXT3 S SOU EXTENSION 3 FILED
Jun 3, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 7, 2024 EX2G S SOU EXTENSION 2 GRANTED
Dec 6, 2024 EXT2 S SOU EXTENSION 2 FILED
Dec 6, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 13, 2024 EXT1 S SOU EXTENSION 1 FILED
Jun 13, 2024 EX1G S SOU EXTENSION 1 GRANTED
Jun 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 19, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2023 DOCK D ASSIGNED TO EXAMINER
Dec 28, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of neurological disorders
Class 044
Providing health information to patients and healthcare professionals relating to diagnosis and treatment of neurological disorders; providing information relating to patient access to diagnosis and treatment of neurological disorders via a website

Classification

International Classes
005 044

USPTO Documents

Loading USPTO documents...